Sort
64,565 grants matching “drug discovery”
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,150William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
The Physiology of Store-Operated Channels in the Nervous System
$963,134Murali Prakriya · Northwestern University At Chicago · R35 · FY2025 · NS
Structure and Function of Neurotransmitter Transporters
$962,713Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2006 · DA
Research Infrastructure Core
$962,695Renato J Aguilera · University Of Texas El Paso · U54 · FY2022 · MD
CCR Office of Training and Education
$962,599Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2019 · CA
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics
$962,495Stephanie K Florio · Anagin · U44 · FY2022 · NS
Exploration, conservation, & development of marine biodiversity in Fiji
$962,345Mark E Hay · Georgia Institute Of Technology · U01 · FY2010 · TW
Genetic Determinants of Epilepsy in Murine Systems
$962,316Tristan T Sands · Columbia University Health Sciences · R01 · FY2023 · NS
DCTD Human Toxicology and Pharmacology
$962,236David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Screening Core
$962,209James Robert Bostwick · University Of Alabama At Birmingham · U19 · FY2018 · AI
Genomic Medicine Implementation: The Personalized Medicine Program
$962,192Julie A. Johnson · University Of Florida · U01 · FY2015 · HG
SMALL MOLECULE ANTAGONISTS OF PF4 FOR THE TREATMENT AND PREVENTION OF HIT
$962,140Bruce S Sachais · Fox Chase Chemical Diversity Center, Inc · R42 · FY2017 · HL
Cellular Mechanisms Of Xenobiotic Transport
$961,983David Miller · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$961,969John Blangero · University Of Texas Rio Grande Valley · R01 · FY2016 · HL
Ultra-High-Throughput Plate Reader for Drug Discovery Using All-Optical Electrophysiology
$961,962Yang Lu · Quiver Bioscience Inc. · R44 · FY2023 · NS
4-(Aminomethyl) benzamides as novel anti-Ebola agents
$961,660Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2020 · AI
Lung fibrosis modeling and compound testing platform using fibrotic lung ECM that recreates the fibrotic disease environment to improve predictiveness and accelerate anti-fibrotic drug development
$961,355John David O'Neill · Xylyx Bio, Inc. · R44 · FY2023 · HL
REPTOR: accelerating antibody discovery and improving hits with machine learning
$961,244Natalie Castellana · Abterra Biosciences, Inc. · R44 · FY2025 · GM
NOVEL STRATEGIES FOR PLANT-DERIVED ANTICANCER AGENTS
$961,095University Of Illinois At Chicago · U19 · FY2003 · CA
Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma
$961,015Kevin D Mills · Cyteir Therapeutics, Inc. · R42 · FY2017 · CA
Accelerated discovery of methylation targeted therapeutic development
$960,546Zu-Wen Sun · Epicypher, Inc. · R44 · FY2019 · CA
Targeting Mutant KRAS for Cancer Therapy
$960,504Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2016 · CA
IGF::OT::IGF Medication Discovery Using Rat Models of Relapse; POP 8/29/2014-7/9/2017; FY16 N01DA-14-8917
$960,399Patrick Beardsley · Virginia Commonwealth University · N01 · FY2017 · DA
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$960,276Richard K. Plemper · Georgia State University · R01 · FY2022 · AI
Solution Phase Libraries by Fluorous Mixture Synthesis
$960,248Fluorous Technologies, Inc. · R44 · FY2002 · GM